Details of the Drug
General Information of Drug (ID: DMDO9YM)
| Drug Name |
1-adamantan-1-yl-3-(2-hydroxyethyl)urea
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1-adamantan-1-yl-3-(2-hydroxyethyl)urea; CHEMBL398166; 120615-92-1; NSC98656; 1-(1-adamantyl)-3-(2-hydroxyethyl)urea; AC1L6ASW; Oprea1_805585; CTK8A5210; MolPort-000-709-916; HMS1608K05; ZINC1643992; STK862338; BDBM50223393; IMED57309943; NSC-98656; AKOS023552817; AKOS001482962; MCULE-6824900815; N-1-adamantyl-N'-(2-hydroxyethyl)urea; EN300-234857; SR-01000396891; SR-01000396891-1; F0266-0451
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 238.33 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


